The variation of faecal calprotectin after 3 months of anti-TNF therapy is a predictor of sustained clinical remission in patients with Crohn's disease - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement
Poster De Conférence Année : 2018

The variation of faecal calprotectin after 3 months of anti-TNF therapy is a predictor of sustained clinical remission in patients with Crohn's disease

Domaines

Hépatologie et Gastroentérologie

Migration ProdInra  : Connectez-vous pour contacter le contributeur

https://hal.inrae.fr/hal-02736175

Soumis le : mardi 2 juin 2020-17:18:34

Dernière modification le : vendredi 20 décembre 2024-03:27:40

Fichier non déposé

Dates et versions

hal-02736175 , version 1 (02-06-2020)

Identifiants

  • HAL Id : hal-02736175 , version 1
  • PRODINRA : 448733
  • WOS : 000427318901281

Citer

E. Sollelis, R. Minet Quinard, G. Bouguen, Marion Goutte, F. Goutorbe, et al.. The variation of faecal calprotectin after 3 months of anti-TNF therapy is a predictor of sustained clinical remission in patients with Crohn's disease. Congress of ECCO - European Crohn's and Colitis Organisation, 2018, Oxford, United Kingdom. Oxford University Press, Journal of Crohn's and Colitis, 12, 2018, Congress of ECCO - European Crohn's and Colitis Organisation. ⟨hal-02736175⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-RENNES1 PRES_CLERMONT INRA FNCLCC ICO GAUDUCHEAU NUMECAN NUMECAN-EXPRES UR1-UFR-SVE M2ISH UNIV-RENNES INRAE UR1-BIO-SA
30 Consultations
0 Téléchargements

Partager

More